Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Moderna Inc., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net income (loss) 8,362 12,202 (747) (514) (385)
Stock-based compensation 226 142 93 81 73
Depreciation and amortization 348 232 31 31 25
Leased assets expensed 62
Amortization/accretion of investments 31 54 10 (4) (2)
Deferred income taxes (559) (318)
Other non-cash items 28 1
Accounts receivable 1,790 (1,784) (1,385) 7 1
Prepaid expenses and other assets (1,699) (489) (241) 10 (5)
Inventory 492 (1,394) (47)
Right-of-use assets, operating leases 21 (58) (11) (6)
Accounts payable 240 204 12 (24) 15
Accrued liabilities 612 989 388 (3) 9
Deferred revenue (4,157) 2,824 3,842 (44) (65)
Income taxes payable (828) 876
Deferred lease obligation 2
Operating lease liabilities (14) 17 12 13
Other liabilities 88 123 6 (6) 1
Changes in assets and liabilities (3,455) 1,308 2,577 (54) (43)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities (3,381) 1,418 2,774 55 54
Net cash provided by (used in) operating activities 4,981 13,620 2,027 (459) (331)
Purchases of marketable securities (11,435) (12,652) (2,956) (1,145) (1,228)
Proceeds from maturities of marketable securities 3,151 1,338 1,137 993 783
Proceeds from sales of marketable securities 3,548 3,105 215 169 177
Purchases of property, plant and equipment (400) (284) (67) (32) (106)
Investment in convertible notes and equity securities (40) (30)
Decrease in restricted cash 1
Net cash used in investing activities (5,176) (8,523) (1,672) (15) (372)
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs 661
Proceeds from offerings of common stock, net of issuance costs 1,853 563
Repurchases of redeemable convertible preferred stock (8)
Proceeds from issuance of common stock through equity plans 65 124 187 50 1
Repurchases of common stock (3,329) (857)
Charges to financing lease liabilities (184) (140) (6) 1
Reimbursement of assets under financing lease obligation 12
Payments on financing lease obligation (2)
Net cash provided by (used in) financing activities (3,448) (873) 2,033 51 1,227
Net increase (decrease) in cash, cash equivalents and restricted cash (3,643) 4,224 2,388 (423) 524
Cash, cash equivalents and restricted cash, beginning of year 6,860 2,636 248 670 135
Cash, cash equivalents and restricted cash, end of year 3,217 6,860 2,636 248 658

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Cash flow statement item Description The company
Net cash provided by (used in) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Moderna Inc. net cash provided by (used in) operating activities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022 not reaching 2020 level.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Moderna Inc. net cash used in investing activities decreased from 2020 to 2021 but then slightly increased from 2021 to 2022.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Moderna Inc. net cash provided by (used in) financing activities decreased from 2020 to 2021 and from 2021 to 2022.